Toowong Tower
Suite 302 Level 3 9 Sherwood Road
Toowong, QLD 4066
Australia
61 13 0055 0310
https://www.anteristech.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Matthew McDonnell | Chief Financial Officer | 548,77k | N/A | N/A |
Mr. David St. Denis | Chief Operating Officer | 1,07M | N/A | N/A |
Mr. Stephen Denaro | Independent Non-Executive Director & Company Secretary | 221,6k | N/A | N/A |
Dejan Toracki | Corporate Development Director | N/A | N/A | N/A |
Dr. Chris Meduri M.D., M.P.H. | Chief Medical Officer & Member of Medical Advisory Board | N/A | N/A | N/A |
Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Anteris Technologies Ltds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.